Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061778) titled 'Clinical Assessment of Ptosis' on June 3.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Tsurumi University
Condition:
Condition - ptosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Conduct a clinical evaluation of ptosis
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - surgery and eye drops
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - Patients aged 20 to 100 present with ptosis.
Key exclusion criteria - Patients with a history of eye surgery within the past 6 months were excluded.
Target Size - 60
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 06 Month 03 Day
Date of IRB - 2026 Year 12 Month 31 Day
Anticipated trial start date - 2026 Year 06 Month 03 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070691
Disclaimer: Curated by HT Syndication.
